Immunocore Holdings IMCR
NASDAQ IMCR
$30.66 -0.19 (-0.62%)
As of: Sep 30, 2026 · 9:36 AM EDT

Immunocore Holdings (IMCR) Operating Expenses (2021 - 2026)

Updated

Immunocore Holdings' Operating Expenses was $117.84 million in Q2 2026, up 5.4% from $111.8 million a year earlier and up 19.1% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Operating Expenses (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Immunocore Holdings' Operating Expenses was $448.62 million through Jun 30, 2026, up 12.2% year-over-year; for FY2025, it came in at $440.28 million, up 16.5% from FY2024.

  • Operating Expenses has now increased for three consecutive years, with a five-year compound annual growth rate of 22.6% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $377.93 million in FY2024 (+22.7%), $308.04 million in FY2023 (+43.6%), $214.52 million in FY2022 (-3.5%) and $222.38 million in FY2021 (+39.7%).
  • Quarterly Operating Expenses has moved between $41.21 million (Q3 2022) and $121.47 million (Q4 2025) over five years.
  • Compared with a year earlier, Operating Expenses has increased for five straight quarters, with growth averaging 13.2% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q3 2023 (growth of 91.0%); the worst was Q3 2022 (a decline of 18.9%).
  • Per Business Quant data, IMCR's Operating Expenses in the three quarters before Q2 2026 was $98.96 million (Q1 2026), $121.47 million (Q4 2025) and $110.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Immunocore Holdings 1.58 Bn -1.90 Bn 114.84 Mn 117.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.84 Mn
Mar 31, 2026 98.96 Mn
Dec 31, 2025 121.47 Mn
Sep 30, 2025 110.35 Mn
Jun 30, 2025 111.80 Mn
Mar 31, 2025 96.67 Mn
Dec 31, 2024 103.17 Mn
Sep 30, 2024 88.30 Mn
Jun 30, 2024 89.71 Mn
Mar 31, 2024 96.75 Mn
Dec 31, 2023 87.01 Mn
Sep 30, 2023 78.72 Mn
Jun 30, 2023 78.40 Mn
Mar 31, 2023 69.14 Mn
Dec 31, 2022 82.43 Mn
Sep 30, 2022 41.21 Mn
Jun 30, 2022 50.69 Mn
Dec 31, 2021 59.90 Mn
Sep 30, 2021 50.80 Mn
API Access

Immunocore Holdings Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=IMCR&period=max&api_key=YOUR_API_KEY